MEDS (MEDS) common stock.
Latest reported MEDS revenue for 2025-12-31 was $23.3M. Net income was -$101.3M. Revenue was up 28.7% from 2024-12-31 to 2025-12-31.
Use this MEDS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MEDS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MEDS SEC filings page. Lician reads the product cache first so this HTML stays unique to MEDS even when a live quote feed is slow.
Latest cached year on this hub. Full MEDS income, balance, and cash tables.